158 related articles for article (PubMed ID: 14727906)
1. Evaluation of quick disintegrating calcium carbonate tablets.
Fausett H; Gayser C; Dash AK
AAPS PharmSciTech; 2000 Jul; 1(3):E20. PubMed ID: 14727906
[TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
Sano S; Iwao Y; Kimura S; Itai S
Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
[TBL] [Abstract][Full Text] [Related]
3. Development of Coprocessed Chitin-Calcium Carbonate as Multifunctional Tablet Excipient for Direct Compression, Part 2: Tableting Properties.
Chaheen M; Bataille B; Yassine A; Belamie E; Sharkawi T
J Pharm Sci; 2019 Oct; 108(10):3319-3328. PubMed ID: 31145923
[TBL] [Abstract][Full Text] [Related]
4. Consumer vinegar test for determining calcium disintegration.
Mason NA; Patel JD; Dressman JB; Shimp LA
Am J Hosp Pharm; 1992 Sep; 49(9):2218-22. PubMed ID: 1524066
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
[TBL] [Abstract][Full Text] [Related]
6. Formulation and evaluation of nanocrystalline cellulose as a potential disintegrant.
Wang C; Huang H; Jia M; Jin S; Zhao W; Cha R
Carbohydr Polym; 2015 Oct; 130():275-9. PubMed ID: 26076627
[TBL] [Abstract][Full Text] [Related]
7. Functionalized calcium carbonate as a novel pharmaceutical excipient for the preparation of orally dispersible tablets.
Stirnimann T; Di Maiuta N; Gerard DE; Alles R; Huwyler J; Puchkov M
Pharm Res; 2013 Jul; 30(7):1915-25. PubMed ID: 23604923
[TBL] [Abstract][Full Text] [Related]
8. The suitability of disintegrating force kinetics for studying the effect of manufacturing parameters on spironolactone tablet properties.
Massimo G; Santi P; Colombo G; Nicoli S; Zani F; Colombo P; Bettini R
AAPS PharmSciTech; 2003; 4(2):E17. PubMed ID: 12916899
[TBL] [Abstract][Full Text] [Related]
9. Influence of pH on in vitro disintegration of phosphate binders.
Stamatakis MK; Alderman JM; Meyer-Stout PJ
Am J Kidney Dis; 1998 Nov; 32(5):808-12. PubMed ID: 9820451
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of disintegrating time of rapidly disintegrating tablets by a paddle method.
Que L; Wu W; Cheng X; Hu T
Pharm Dev Technol; 2006; 11(3):295-301. PubMed ID: 16895840
[TBL] [Abstract][Full Text] [Related]
11. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
Jung HA; Augsburger LL
Drug Dev Ind Pharm; 2012 Jul; 38(7):825-36. PubMed ID: 22091970
[TBL] [Abstract][Full Text] [Related]
12. Physico-chemical comparison of famotidine tablets prepared via dry granulation and direct compression techniques.
Baseer A; Hassan F; Hassan SF; Jabeen S; Israr F; Murtaza G; Haque N
Pak J Pharm Sci; 2013 May; 26(3):439-43. PubMed ID: 23625414
[TBL] [Abstract][Full Text] [Related]
13. In vitro dissolution of calcium carbonate preparations.
Brennan MJ; Duncan WE; Wartofsky L; Butler VM; Wray HL
Calcif Tissue Int; 1991 Nov; 49(5):308-12. PubMed ID: 1782571
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of disintegration properties of orally rapidly disintegrating tablets using a novel disintegration tester.
Kondo K; Niwa T; Danjo K
Chem Pharm Bull (Tokyo); 2012; 60(10):1240-8. PubMed ID: 23036967
[TBL] [Abstract][Full Text] [Related]
15. Assessment of ferula Gummosa gum as a binding agent in tablet formulations.
Enauyatifard R; Azadbakht M; Fadakar Y
Acta Pol Pharm; 2012; 69(2):291-8. PubMed ID: 22568044
[TBL] [Abstract][Full Text] [Related]
16. Acid-treated yeast cell wall as a binder displaying function of disintegrant.
Ozeki T; Katsuyama H; Yasuzawa Y; Takashima Y; Kasai T; Eguchi T; Kakiuchi H; Yuasa H; Okada H
AAPS PharmSciTech; 2003; 4(3):E41. PubMed ID: 14621973
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
Uhumwangho MU; Okor RS
Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
[TBL] [Abstract][Full Text] [Related]
18. Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.
Rawas-Qalaji MM; Simons FE; Simons KJ
AAPS PharmSciTech; 2006 Apr; 7(2):E41. PubMed ID: 16796358
[TBL] [Abstract][Full Text] [Related]
19. Disintegration of highly soluble immediate release tablets: a surrogate for dissolution.
Gupta A; Hunt RL; Shah RB; Sayeed VA; Khan MA
AAPS PharmSciTech; 2009; 10(2):495-9. PubMed ID: 19387843
[TBL] [Abstract][Full Text] [Related]
20. The Milky Way: paediatric milk-based dispersible tablets prepared by direct compression - a proof-of-concept study.
Orubu SE; Hobson NJ; Basit AW; Tuleu C
J Pharm Pharmacol; 2017 Apr; 69(4):417-431. PubMed ID: 27349946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
